Xenetic Biosciences is a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.
Our XCART™ platform is a novel CAR T technology engineered to target patient- and tumor-specific neoantigens.
Our proprietary and patented technologies are being utilized to create life-changing therapies.
May 19, 2020
May 14, 2020
Stay informed about our latest news and updates